The largest database of trusted experimental protocols

Luna 5 m c18 2 100

Manufactured by Phenomenex
Sourced in Italy

The Luna 5 µm C18(2) 100 Å is a reversed-phase high-performance liquid chromatography (HPLC) column. It features a 5 µm particle size and a 100 Å pore size, designed for the separation and analysis of a wide range of organic compounds.

Automatically generated - may contain errors

6 protocols using luna 5 m c18 2 100

1

Spectroscopic Characterization of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The specific rotation values and IR spectra were measured using a JASCO P-2000 digital polarimeter and a THERMO Scientific Nicolet iS5 FT-IR spectrophotometer, respectively. ESIMS and HRESIMS were recorded using a BRUKER 7 Tesla solariX FTMS system. NMR spectra were obtained from a JEOL Resonance ECZ 400S or an ECZ 600R NMR spectrometer, with the residual signals of CHCl3 (δH 7.26 ppm) and CDCl3 (δC 77.0 ppm) used as the internal standards for 1H and 13C NMR, respectively. Coupling constants (J) are provided in Hz. Column chromatography was carried out with a silica gel (230~400 mesh, MERCK) column. Thin-layer chromatography was performed on plates precoated with silica gel 60 F254 (0.25-mm-thick, MERCK); the plates then sprayed with 10% (v/v) H2SO4 in methanol, followed by heating to visualize the spots. A normal-phase (NP) HPLC was performed using a system comprised of a HITACHI 5110 pump, a RHEODYNE 7725i injection port and a NP column (YMC pack SIL, 5 μm, 12 nm, 250 × 20 mm, YMC group). Reverse-phase (RP) HPLC was performed using a system comprised of a HITACHI L-2130 pump, a HITACHI L-2455 photodiode array detector, a RHEODYNE 7725i injection port and a RP column (Luna 5 µm C18(2) 100 Å, 250 × 21.2 mm, Phenomenex).
+ Open protocol
+ Expand
2

Quantification of Zebrafish Metabolic Energy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nucleotide extraction was performed at 5 and 6 dpf, as we previously described [35] (link), but now using a Precellys 24 homogenizer (Bertin Technologies) at 6800 rpm (3 ×20 s, CK28 beads). ATP, ADP and AMP were quantified using HPLC (reversed-phase column; 250 ×4.6 mm Luna 5 µm C18(2) 100 Å; Phenomenex) with a diode-array detector (Agilent 1100 series), measuring 260 nm absorbance. Energy charge was calculated with the formula: ([ATP]+0.5[ADP]) ÷ ([ATP]+[ADP]+[AMP]) [49] (link).
+ Open protocol
+ Expand
3

Isolation and Decarboxylation of CBDHA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A semi-preparative LC system (Octave 10 Semba Bioscience, Madison, USA) was used to separate the FM2 mixture into 80 fractions in a total run time of 80 min. The chromatographic conditions used are reported in the paper by Citti et al.4 (link). A Luna C18 with a fully porous silica stationary phase (Luna 5 µm C18(2) 100 Å, 250 × 10 mm) (Phenomenex, Bologna, Italy) was the column employed and a mixture of acetronitrile:0.1% aqueous formic acid 70:30 (v/v) was used as mobile phase at a constant flow rate of 5 mL/min. The fractions containing CBDHA (retention time 13.0 min) was isolated as reported in our previous work2 (link). The fractions containing CBDHA (13.0 min) were analyzed by UHPLC-HESI-Orbitrap and dried on the rotavapor at 70 °C. The residue was placed in an oven at 120 °C for 2 h to achieve decarboxylation. An amount of about 0.3 mg of CBDH was obtained.
+ Open protocol
+ Expand
4

Isolation and Decarboxylation of Cannabinoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aliquots (1 mL) of the solution obtained as described in the ‘Plant Material’ section were injected in a semi-preparative LC system (Octave 10 Semba Bioscience, Madison, USA). The chromatographic conditions used are reported in the paper by Citti et al.11 (link). The column employed was a Luna C18 with a fully porous silica stationary phase (Luna 5 µm C18(2) 100 Å, 250 × 10 mm) (Phenomenex, Bologna, Italy) and a mixture of acetronitrile:0.1% aqueous formic acid 70:30 (v/v) was used as mobile phase at a flow rate of 5 mL/min. CBDPA and THCPA (retention time 19.0 min and 75.5 min respectively) were isolated as reported in our previous work11 (link). The fractions containing CBDPA and THCPA were analyzed by UHPLC-HESI-Orbitrap. The fractions containing predominantly either one or the other cannabinoid were separately combined and dried on the rotavapor at 70 °C. Each residue was subject to decarboxylation at 120 °C for two hours in oven. An amount of about 0.6 mg of CBDP and about 0.3 mg of Δ9-THCP was obtained.
+ Open protocol
+ Expand
5

Purification of Antioxidant Fractions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fractions with higher antioxidant were further purified by RP-HPLC using a Luna 5 µm C18(2) 100 Å, 250 × 10 mm LC column (Phenomenex., Torrance, CA, USA), attached to the Dionex Chromeleon 7.2 chromatography system (Thermo Fisher Scientific, Waltham, MA, USA.). Separation was performed with solution A (0.1% formic acid in deionized water) and solution B (0.1% formic acid in acetonitrile) eluted with a linear gradient of acetonitrile (0–5 min, 90% of solution A and 10% of solution B; 6–55 min, 20% of solution A and 80% of solution B; 56–60 min, 20% of solution A and 80% of solution B; 60–66 min, 90% of solution A and 10% of solution B) at a flow rate of 1 mL/min. Absorbance was monitored at 214 nm.
+ Open protocol
+ Expand
6

Antrodia cinnamomea Extract Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two hundred grams of air-dried fruiting bodies of Antrodia cinnamomea were ground into fine powder using a mini blender (DM-6, Youqi, Taiwan) and extracted with 95% ethanol at ambient temperature (3 × 2.0 L). The slurry was filtered and the filtrate was concentrated under reduced pressure to yield a dark-brown residue of 38.9 g as the crude extract, which was suspended in water (1.0 L) and extracted with hexane (HE), diethyl ether (DE), ethyl acetate (EA), and n-butanol (Bu), sequentially. The fractions were dissolved in DMSO (0.1 g/mL) for the screening of anti-inflammatory activity.
The crude fractions with promising activities were further separated by semi-prep HPLC using the Waters Purification System equipped with a 2998 PDA Detector and a 2707 AUTOSAMPLER. A HPLC column (Luna 5 µM C18(2) 100 Å, 250mm × 10 mm; Phenomenex) was employed with two solvent systems: H2O with 0.1% formic acid (A) and MeOH (B).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!